FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385219001: Conventional release solution for injection (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2647441017 Solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3620906015 Conventional release solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3620907012 Conventional release solution for injection (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
36581000188117 solution injectable fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
260561000077117 solution pour injection fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Solution for injection Is a injection false Inferred relationship Some
Solution for injection Is a Drug solution false Inferred relationship Some
Solution for injection Is a Parenteral dose form (dose form) false Inferred relationship Some
Solution for injection Has dose form administration method (attribute) A method of administration of a dose form by introducing it into the body, usually after puncturing the skin; typically used for small volumes of liquid administered over a brief duration. true Inferred relationship Some
Solution for injection Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration by injection. true Inferred relationship Some
Solution for injection Has dose form release characteristic (attribute) A release characteristic where a dose form displays a rate and time of release of the active substance(s) in the dose form based on their intrinsic properties. true Inferred relationship Some
Solution for injection Has basic dose form (attribute) Solution true Inferred relationship Some
Solution for injection Has dose form transformation (attribute) No transformation true Inferred relationship Some
Solution for injection Is a Solution for infusion and/or injection true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Interferon beta-1a 60 microgram/mL solution for injection Has manufactured dose form True Solution for injection Inferred relationship Some
Etanercept 49.01 mg/mL solution for injection Has manufactured dose form True Solution for injection Inferred relationship Some
Product containing precisely etanercept 51.02 milligram/1 milliliter conventional release solution for injection (clinical drug) Has manufactured dose form True Solution for injection Inferred relationship Some
Product containing precisely isoniazid 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has manufactured dose form True Solution for injection Inferred relationship Some
Conventional release intravesical solution and solution for injection (dose form) Is a True Solution for injection Inferred relationship Some
Product containing precisely inclisiran (as inclisiran sodium) 189 milligram/1 milliliter conventional release solution for injection (clinical drug) Has manufactured dose form True Solution for injection Inferred relationship Some
Product containing precisely pegvaliase 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has manufactured dose form True Solution for injection Inferred relationship Some
Pegvaliase 2.5 mg/mL solution for injection Has manufactured dose form True Solution for injection Inferred relationship Some
Pegvaliase 20 mg/mL solution for injection Has manufactured dose form True Solution for injection Inferred relationship Some
Product containing precisely pertuzumab 80 milligram/1 milliliter and trastuzumab 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Has manufactured dose form True Solution for injection Inferred relationship Some
Product containing precisely pertuzumab 60 milligram/1 milliliter and trastuzumab 60 milligram/1 milliliter conventional release solution for injection (clinical drug) Has manufactured dose form True Solution for injection Inferred relationship Some
Tezepelumab 110 mg/mL solution for injection Has manufactured dose form True Solution for injection Inferred relationship Some
Belimumab 200 mg/mL solution for injection Has manufactured dose form True Solution for injection Inferred relationship Some
Product containing precisely insulin degludec 100 unit/1 milliliter and liraglutide 3.6 milligram/1 milliliter conventional release solution for injection (clinical drug) Has manufactured dose form True Solution for injection Inferred relationship Some
Product containing precisely lauromacrogol 400 30 milligram/1 milliliter conventional release solution for injection (clinical drug) Has manufactured dose form True Solution for injection Inferred relationship Some
Product containing precisely interferon alfa-2b (as ropeginterferon alfa-2b) 500 microgram/1 milliliter conventional release solution for injection (clinical drug) Has manufactured dose form True Solution for injection Inferred relationship Some
Product containing precisely glucose 50 milligram/1 milliliter and sodium chloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) Has manufactured dose form True Solution for injection Inferred relationship Some
Sodium chloride 30 mg/mL solution for injection Has manufactured dose form True Solution for injection Inferred relationship Some
Glucose 250 mg/mL solution for injection Has manufactured dose form True Solution for injection Inferred relationship Some
Bimekizumab 160 mg/mL solution for injection Has manufactured dose form True Solution for injection Inferred relationship Some
Product containing precisely tralokinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has manufactured dose form True Solution for injection Inferred relationship Some
Natalizumab 150 mg/mL solution for injection Has manufactured dose form True Solution for injection Inferred relationship Some
Histamine dihydrochloride 1 mg/mL solution for injection Has manufactured dose form True Solution for injection Inferred relationship Some
Bortezomib 2.5 mg/mL solution for injection Has manufactured dose form True Solution for injection Inferred relationship Some

Start Previous Page 29 of 29

Reference Sets

Description inactivation indicator reference set

GB English

Back to Start